Chapin Davis’s Humana HUM Stock Holding History

Chapin Davis’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,391	Closed	-$712K	–	233
2022 Q4	$712K	Buy	+1,391	New	+$731K	0.41%	70

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Chapin Davis's HUM Position: Q1 2023 in Review

Chapin Davis sold out of Humana (HUM) in Q1 2023, closing a stake of 1,391 shares — an estimated $712K sold.

Chapin Davis first reported a position in HUM in Q4 2022 and held it in 1 quarter. The position peaked at $712K in Q4 2022. 1,045 funds tracked by Wall St. Rank hold HUM as of Q1 2023.

Chapin Davis reported no remaining Humana position as of Q1 2023 after selling out during the quarter.
Chapin Davis sold 1,391 Humana shares in Q1 2023, an estimated $712K.
Chapin Davis first reported a position in Humana in Q4 2022 and held it in 1 quarter.
Chapin Davis's Humana position peaked at $712K in Q4 2022.
1,045 funds tracked by Wall St. Rank held Humana as of Q1 2023.

Based on Chapin Davis's 13F filing for Q1 2023, filed 13 Apr 2023.